Clinical Trial Update: The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions. [Phase 3]

View source ↗

Summary

Phase 3 trial of the BX VELOCITY stent for de novo coronary artery lesions has completed enrollment and status is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED